Antibody-polymer combined body and fluorescent derivative thereof and preparation method of antibody-polymer combined body and fluorescent derivative

A technology of polymer conjugates and polymer monomers, applied in the field of biomedicine, can solve problems such as difficult separation of products, difficulty in maintaining activity, poor quality control, etc., and achieve the effect of simple steps

Active Publication Date: 2015-01-21
TSINGHUA UNIV
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The traditional synthesis method of antibody-polymer conjugates is to link pre-prepared polymers with antibodies, which often has uncertain coupling sites, low efficiency, poor yield, difficult separation of products, poor quality control, and difficult activity. Keeping (the reaction site is close to the antibody active site) and many other problems

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody-polymer combined body and fluorescent derivative thereof and preparation method of antibody-polymer combined body and fluorescent derivative
  • Antibody-polymer combined body and fluorescent derivative thereof and preparation method of antibody-polymer combined body and fluorescent derivative
  • Antibody-polymer combined body and fluorescent derivative thereof and preparation method of antibody-polymer combined body and fluorescent derivative

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0070]Specifically, the preparation method may include two methods: the first is an in-situ polymerization method, and the method includes: a1) preparing an antibody-initiator conjugate, wherein the elicitor is bound to the disulfide of the antibody bond or free sulfhydryl group; b1) the antibody-initiator conjugate is mixed with a polymer monomer or a polymer monomer and a fluorescent monomer in a buffer, and triggers the polymerization of the polymer monomer under the action of a catalyst And the antibody-macromolecule conjugate or the fluorescent derivative of the antibody-polymer conjugate is prepared. The second is the grafting method. The grafting method pre-prepared the polymer, and then coupled with the specific site of the antibody to prepare the antibody-polymer conjugate and its fluorescent derivatives. The method includes: a2) the initiator is placed in the catalyst Initiate the polymerization of polymer monomers or polymer monomers and fluorescent monomers under t...

Embodiment 1

[0095] 1. Preparation of ATRP initiator DBEB (chemical formula I-2).

[0096]

[0097] Preparation of 3,4-dibromo-1-((2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)methyl)-1H-pyrrole-2,5-dione (chemical formula I-1): Dibromomaleimide (1.02g, 4mmol) was dissolved in 20ml of dry tetrahydrofuran, and triphenylphosphine (1.05g, 4mmol) and diisopropyl azodicarboxylate were slowly added at room temperature (DIAD, 790 μL, 4 mmol) and tetraethylene glycol (1.4 ml, 8 mmol) and stirred for 20 hours. Use a rotary evaporator to remove the solvent, dry loading, and flash column chromatography to obtain the compound (yellow oil, 398mg, yield rate 23%) described in the chemical formula I-1 provided by the invention, and reclaimed 50% of the dibromo Substitute maleimide.

[0098] The compound of chemical formula I-1 is a yellow oil. 1 H NMR (CDCl 3 , 400MHz) δ3.59-3.71(m, 14H), 3.81-3.84(m, 2H). 13 C NMR (CDCl 3 , 100MHz) δ39.0, 61.8, 67.7, 70.1, 70.4, 70.6, 70.8, 72.6, 129.5, 164.0. MS (IES) ...

Embodiment 2

[0126] 1. Preparation of rhodamine B derivative fluorescent monomer (formula I-6)

[0127]

[0128] 1) Synthesis of 3-bromopropyl methacrylate (chemical formula I-3).

[0129] Methacryloyl chloride (1.04g, 10mmol) and 3ml of triethylamine were slowly added dropwise to a mixed solution of 3-bromopropanol (1.39g, 10mmol) in dichloromethane (20ml) and DFM (1ml). After reacting at room temperature for 12 hours, 0.1M dilute hydrochloric acid was slowly added dropwise to the reaction solution until pH<7.0, extracted with ethyl acetate (3×25 mL), the organic phase was dried over anhydrous magnesium sulfate, filtered and concentrated. Flash column chromatography obtained the compound of chemical formula I-3 provided by the present invention (colorless oil, 1.13 g, 55%).

[0130] The compound of formula I-3 is a yellow oil. 1 H NMR (400MHz, CDCl 3 )δ1.95(s, 3H), 2.21-2.27(m, 2H), 3.49(t, 2H, J=6.4), 4.29(t, 2H, J=6.4), 5.58(s, 1H), 6.11( s, 1H). MS (ESI) m / z: 229 [M+Na] + .

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses an antibody-polymer combined body and a fluorescent derivative thereof and a preparation method of the antibody-polymer combined body and the fluorescent derivative. The antibody comprises at least one disulfide bond or free sulfydryl; the polymer is combined to the antibody through connection to the disulfide bond or free sulfydryl of the antibody; according to the method, a specific site of the antibody is modified; a polymer and a fluorescent derivative thereof grow in situ; or a polymer and a fluorescent derivative thereof are prepared in advance; and the antibody-polymer combined body and the fluorescent derivative thereof are prepared in a manner of specific site coupling of the antibody. The method disclosed by the invention is simple, convenient and efficient; the prepared product not only reserves the original biological activity of the antibody, but also improves the water solubility, stability, pharmacokinetics, distribution of organisms and treatment efficacy; the immunogenicity is reduced; in addition, compared with an antibody-fluorescence indicator prepared by the traditional method, the antibody-polymer fluorescent derivative prepared by the method has stronger fluorescence signal and detection signal strength.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a preparation method of an antibody-macromolecule conjugate and a fluorescent derivative thereof. Background technique [0002] As the most important immune protein in the body, antibodies have been widely used in many fields such as biomedical imaging, targeted therapy, and clinical diagnosis. Antibodies used alone have problems such as short half-life and poor solubility. Linking polymers to antibodies to prepare antibody-polymer conjugates can effectively improve the solubility, stability, pharmacokinetics and therapeutic efficacy of antibodies and reduce their immunogenicity. The traditional synthesis method of antibody-polymer conjugates is to link pre-prepared polymers with antibodies, which often has uncertain coupling sites, low efficiency, poor yield, difficult separation of products, poor quality control, and difficult activity. Keeping (the reaction site is close to the an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/48A61K39/395A61K49/00C08F120/28C08F220/28C08F220/36C09K11/06G01N21/64G01N33/531
CPCA61K49/0058A61K47/60C07K16/32C09B11/24C09B69/103C09K11/06C08F220/286G01N21/6428G01N33/52G01N2021/6439
Inventor 高卫平张立彬
Owner TSINGHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap